Patient Reported Outcome Measures (PROMs) in Rehabilitation With or Without the Possible Use of a Mobile Application After Primary Knee or Hip Arthroplasty

NCT04628468 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 416

Last updated 2023-07-07

No results posted yet for this study

Summary

Rehabilitation after primary knee or hip arthroplasty may include performing exercises with a physiotherapist. For patients who can work well with a computer, tablet or smartphone, it is now possible to use a mobile application (e.g. moveUp) to carry out a large part of the exercises more independently. This is done with online guidance by a physiotherapist via a mobile application that is CE marked in Europe.

This study will investigate whether the effect of the mobile application on knee or hip rehabilitation and quality of life is equal to that of standard care (i.e. without the use of a mobile application).

Conditions

  • Arthroplasty, Replacement, Knee
  • Rehabilitation
  • Hip Arthrosis

Interventions

DEVICE

moveUp

Mobile application for use in the rehabilitation of primary knee and hip arthroplasty

OTHER

Predefined number of traditional physiotherapy sessions

exercises with a physiotherapist being physically present

Sponsors & Collaborators

  • National Institute for Health and Disability Insurance (NIHDI), Belgium

    collaborator UNKNOWN
  • Belgium Health Care Knowledge Centre

    collaborator OTHER_GOV
  • University Hospital, Ghent

    lead OTHER

Principal Investigators

  • Catherine Van Der Straeten, Professor · Health, Innovation and Research Institute UZ Ghent

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-18
Primary Completion
2023-05-29
Completion
2023-05-29

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04628468 on ClinicalTrials.gov